Editorial: Pharmacogenomics in neglected populations

Editorial: Pharmacogenomics in neglected populations

Bibliographic Details
Main Authors:	Mariana R. Botton, Jorge Duconge, Fernanda Rodrigues-Soares
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Series:	Frontiers in Pharmacology
Subjects:	pharmacogenomics (PGx) population genetics ancestry pharmacogenetics drug metabolism
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.1081117/full

Similar Items

Editorial: Translation and implementation of pharmacogenomic testing in daily clinical practice: Considering current challenges and future needs
by: Wojciech Miltyk, et al.
Published: (2022-11-01)

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023-03-01)

The Status Quo of Pharmacogenomics of Tyrosine Kinase Inhibitors in Precision Oncology: A Bibliometric Analysis of the Literature
by: Abdallah Alzoubi, et al.
Published: (2024-01-01)

Pharmacogenomics and health disparities, are we helping?
by: Sherin Shaaban, et al.
Published: (2023-01-01)

Editorial: Precision psychiatry from a pharmacogenetics perspective
by: Lisa C. Brown, et al.
Published: (2023-03-01)

High-Evidence, Actionable Phenotype Gene Distribution in a Multispecialty, Tertiary Care Clinic: Potentially Actionable Genes and a Referring Department Profile
by: Blake Bartlett, et al.
Published: (2023-06-01)

Pharmacogenomics /
by: Kalow, Werner, et al.
Published: (2005)

Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand
by: Napatrupron Koomdee, et al.
Published: (2022-04-01)

Pharmacogenomics : methods and applications /
by: 247902 Innocenti, Federico
Published: (2005)

INTEGRATING PHARMACOGENOMICS INTO CLINICAL PRACTICE
by: Gurinder Johal, et al.
Published: (2016-05-01)

Computational pharmacogenotype extraction from clinical next-generation sequencing
by: Tyler Shugg, et al.
Published: (2023-07-01)

The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation
by: Alexandra Brady, et al.
Published: (2023-08-01)

The concept of gene is in crisis. Does it affect pharmacogenetics and pharmacogenomics?
by: Miriam Falkenberg, et al.
Published: (2006-09-01)

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
by: José A. G. Agúndez, et al.
Published: (2023-08-01)

The pharmacogenomic landscape of an Indigenous Australian population
by: Sumudu Rangika Samarasinghe, et al.
Published: (2023-05-01)

Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics
by: Maria-Theodora Pandi, et al.
Published: (2020-05-01)

Web Resources for Pharmacogenomics
by: Guoqing Zhang, et al.
Published: (2015-02-01)

Update on the pharmacogenomics of pain management
by: Kaye AD, et al.
Published: (2019-07-01)

Forging the path to precision medicine in Qatar: a public health perspective on pharmacogenomics initiatives
by: Kholoud Bastaki, et al.
Published: (2024-03-01)

Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
by: Francisco Abad-Santos, et al.
Published: (2024-02-01)

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022
by: Francesco Sessa, et al.
Published: (2023-03-01)

Population Pharmacogenomics for Health Equity
by: I. King Jordan, et al.
Published: (2023-09-01)

Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments
by: Marta Hernandez, et al.
Published: (2024-02-01)

Investigation of community pharmacists’ knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice
by: Azza Ramadan, et al.
Published: (2024-01-01)

Pharmacogenetics of pediatric acute lymphoblastic leukemia in Uruguay: adverse events related to induction phase drugs
by: Gabriela Burgueño-Rodríguez, et al.
Published: (2023-11-01)

Editorial: Integration of computational genomics into clinical pharmacogenomic tests: how bioinformatics may help primary care in precision medicine area
by: Alireza Tafazoli, et al.
Published: (2023-08-01)

Pharmacogenomics in practice: a review and implementation guide
by: Danya Kabbani, et al.
Published: (2023-05-01)

Clinical and statistical consideration in personalized medicine /
by: Carini, Claudio, et al.
Published: (2014)

Validation of Pharmacogenomic Interaction Probability (PIP) Scores in Predicting Drug–Gene, Drug–Drug–Gene, and Drug–Gene–Gene Interaction Risks in a Large Patient Population
by: Kristine Ashcraft, et al.
Published: (2022-11-01)

Race, Ethnicity, and Pharmacogenomic Variation in the United States and the United Kingdom
by: Shivam Sharma, et al.
Published: (2023-07-01)

Genetic Variation among Pharmacogenes in the Sardinian Population
by: Maria Laura Idda, et al.
Published: (2022-09-01)

Pharmacogenomics perspective for forensic toxicology: A mini review
by: Dilek Battal, et al.
Published: (2022-12-01)

Addressing disparities in pharmacogenomics through rural and underserved workforce education
by: Jacob T. Brown, et al.
Published: (2023-01-01)

Editorial: Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022
by: Sylvia D. Klomp, et al.
Published: (2023-10-01)

Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders
by: Stefania Zampatti, et al.
Published: (2021-08-01)

Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations
by: Guilherme Suarez-Kurtz
Published: (2023-08-01)

Pharmacogenomics and the Management of Mood Disorders—A Review
by: Kristian Kleine Schaars, et al.
Published: (2023-07-01)

Editorial: The impact of the human genome on interindividual variability in drug response
by: Yaya Kassogue, et al.
Published: (2024-04-01)

Editorial: The Potential of Machine-learning in Pharmacogenetics, Pharmacogenomics and Pharmacoepidemiology: Volume II
by: Augusto Garcia-Agundez, et al.
Published: (2023-08-01)

Editorial: Pharmacogenetics and pharmacogenomics in Latin America: ethnic variability, new insights in advances and perspectives: a RELIVAF-CYTED initiative, Volume II
by: Andrés López-Cortés, et al.
Published: (2023-05-01)